Veru (VERU) Other financing activities (2018 - 2023)
Veru (VERU) posted quarterly Other financing activities of $52448.0 for Q3 2023, down 92.39% year-over-year from $689000.0 in Q3 2022, and up 13548.21% quarter-over-quarter from -$390.0 in Q2 2023.
Veru (VERU) Other financing activities (2018 - 2023) Analysis & Trends
Veru (VERU) has reported Other financing activities for 6 consecutive years, with $52448.0 the latest figure, recorded in Q3 2023.
- In Q3 2023, Other financing activities fell 92.39% year-over-year to $52448.0; the TTM figure through Sep 2025 stood at $52058.0 (down 60.58% YoY), while the FY2024 annual figure was $3280.0, down 99.16% from the prior year.
- Other financing activities climbed to $52448.0 in Q3 2023 per VERU's latest filing, from -$390.0 in the prior quarter.
- Across five years, Other financing activities topped out at $9.4 million in Q2 2019 and bottomed at -$390.0 in Q2 2023.
- Historically, Other financing activities has averaged $858066.2 across 5 years, with a median of $200000.0 in 2019.
- Annual changes were most pronounced in 2021 — Other financing activities jumped 3040.7% — and 2023, when it sank 100.25%.
- Veru's Other financing activities stood at $9.4 million in 2019, then tumbled by 93.36% to $624000.0 in 2020, then sank by 66.35% to $210000.0 in 2021, then advanced by 22.38% to $257000.0 in 2022, then sank by 79.59% to $52448.0 in 2023.
- Business Quant data shows VERU's Other financing activities at $52448.0 in Q3 2023, -$390.0 in Q2 2023, and $80000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Veru | 60.85 Mn | 35.06 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 52,448.00 |
| Sep 30, 2023 | 52,448.00 |
| Jun 30, 2023 | -390.00 |
| Jun 30, 2023 | -390.00 |
| Mar 31, 2023 | 80,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 257,000.00 |
| Dec 31, 2022 | 257,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Sep 30, 2022 | 689,000.00 |
| Jun 30, 2022 | 154,034.00 |
| Jun 30, 2022 | 154,034.00 |
| Mar 31, 2022 | 46,966.00 |
| Mar 31, 2022 | 46,966.00 |
| Dec 31, 2021 | 210,000.00 |
| Dec 31, 2021 | 210,000.00 |
| Sep 30, 2021 | 275,567.00 |
| Sep 30, 2021 | 275,567.00 |
| Jun 30, 2021 | 200,000.00 |
| Jun 30, 2021 | 200,000.00 |